Rani Therapeutics Holdings Inc's Company Valuation
Currency: USD Updated: 2026-07-31
Previous score
6.39
Change
2.37
The current valuation score of Rani Therapeutics Holdings Inc is 8.76, ranking 60 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.86, which is -84.21% below the recent high of -0.45 and -113.04% above the recent low of -6.10.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.